Oxygenta Pharmaceutical Ltd.

OXYGENTAPH

₹101.1

-4.44% (-4.7)

Market Cap

₹374 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

374 Cr

Prom Holding

57.92 %

ROE (%)

17.29

ROCE (%)

-59.31

Div Yield (%)

Sales

110 Cr

OPM (%)

-8.40 %

Debt to Equity

-2.77

Edit Ratio's

About

SS Organics Ltd is a pharmaceutical company involved in the manufacture and marketing of bulk … Read more

Low

52W Range

High

134

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

2 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Sales Growth

Sales of the company has grown at a good pace
ROE

Roe has decreased vs 10 year trend
Capex vs ROCE

Roce of the company has decreased even without significant capex
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Balance Sheet Strength

Balance sheet is weak and might have solvency issues
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Oxygenta Pharmaceutical Ltd. Business

What does Oxygenta Pharma do?

SS Organics Ltd is a pharmaceutical company that focuses on producing and marketing bulk drugs and intermediates, specializing in new-generation medications such as quinolones, antiasthmatics, antiulcerants, and anti-inflammatories.

Who are the competitors of Oxygenta Pharma?

Oxygenta Pharma major competitors are Nectar Lifesciences, Influx Healthtech, Zenotech Laboratorie, Lyka Labs, Trident Lifeline, Kappac Pharma, SMS Lifesciences.
Market Cap of Oxygenta Pharma is ₹374 Crs.
While the median market cap of its peers are ₹352 Crs.

Is Oxygenta Pharma financially stable compared to its competitors?

Oxygenta Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Oxygenta Pharma is 1.37 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Oxygenta Pharmaceutical Ltd.

Oxygenta Pharmaceutical Ltd.

Key Ratios

About

Timeline

Company Timeline

6 Yes

1 Neutral

8 No

2 No Data

Accounting & Shareholding

Depreciation Effect

Other Income

Pledge

Retail Holding

Revenue Recognition

Promoter Holding

Contingent Liabilities

Price & Performance

Sales Growth

ROE

Capex vs ROCE

Debt

Share price

Working Capital

Margin Stability

ROCE Strength

Balance Sheet Strength

Current vs Historic Valuation

Product Wise Break-Up

UNLOCK PREMIUM

What does Oxygenta Pharma do?

Who are the competitors of Oxygenta Pharma?

Is Oxygenta Pharma financially stable compared to its competitors?

SIGN UP FOR FREE